150 related articles for article (PubMed ID: 22579489)
21. Identification of liguzinediol metabolites in rats by ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Shan CX; Li W; Wen HM; Wang XZ; Zhu YH; Cui XB
J Pharm Biomed Anal; 2012 Mar; 62():187-90. PubMed ID: 22277354
[TBL] [Abstract][Full Text] [Related]
22. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
23. Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
Liu D; Jiang J; Zhang L; Tan F; Wang Y; Hu P
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2131-40. PubMed ID: 21732454
[TBL] [Abstract][Full Text] [Related]
24. Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry.
Fang ZG; You BG; Chen YG; Zhang JK; Liu YQ; Zhang XN; Zhang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1153-62. PubMed ID: 20381433
[TBL] [Abstract][Full Text] [Related]
25. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
[TBL] [Abstract][Full Text] [Related]
26. Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control.
Lee KM; Kim HJ; Jeong ES; Yoo HH; Kwon OS; Jin C; Kim DH; Lee J
Rapid Commun Mass Spectrom; 2011 Aug; 25(16):2261-7. PubMed ID: 21755547
[TBL] [Abstract][Full Text] [Related]
27. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
Mazzarino M; Fiacco I; de la Torre X; Botrè F
Eur J Mass Spectrom (Chichester); 2008; 14(3):171-80. PubMed ID: 18708697
[TBL] [Abstract][Full Text] [Related]
28. Determination of raloxifene in urine by liquid chromatography-tandem mass spectrometry for doping.
Chen TT; Huang TY; Pan RN; Chang-Chien GP; Hsu MC
J Anal Toxicol; 2013; 37(6):345-50. PubMed ID: 23772059
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry.
Suchanova B; Kostiainen R; Ketola RA
Eur J Pharm Sci; 2008 Jan; 33(1):91-9. PubMed ID: 18055188
[TBL] [Abstract][Full Text] [Related]
31. Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine.
Pozo OJ; Marcos J; Matabosch X; Ventura R; Segura J
Rapid Commun Mass Spectrom; 2012 Mar; 26(5):541-53. PubMed ID: 22302494
[TBL] [Abstract][Full Text] [Related]
32. New long term metabolite in human urine for metenolone misuse by liquid chromatography quadrupole time-of-flight mass spectrometry.
He G; Yang S; Lu J; Xu Y
Steroids; 2016 Jan; 105():1-11. PubMed ID: 26519767
[TBL] [Abstract][Full Text] [Related]
33. Large scale pesticide multiresidue methods in food combining liquid chromatography--time-of-flight mass spectrometry and tandem mass spectrometry.
García-Reyes JF; Hernando MD; Ferrer C; Molina-Díaz A; Fernández-Alba AR
Anal Chem; 2007 Oct; 79(19):7308-23. PubMed ID: 17718536
[TBL] [Abstract][Full Text] [Related]
34. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry.
Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT
Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304
[TBL] [Abstract][Full Text] [Related]
35. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
[TBL] [Abstract][Full Text] [Related]
36. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
[TBL] [Abstract][Full Text] [Related]
37. Identification and synthesis of (Z)-3'-hydroxy clomiphene as a new potential doping-relevant metabolite of clomiphene.
Euler L; Mürdter T; Heinkele G; Schwab M; Miller GD; Eichner D; Thomas A; Thevis M
Rapid Commun Mass Spectrom; 2023 Sep; 37(17):e9599. PubMed ID: 37580503
[TBL] [Abstract][Full Text] [Related]
38. Identification of new minor metabolites of penicillin G in human serum by multiple-stage tandem mass spectrometry.
Ho HP; Lee RJ; Chen CY; Wang SR; Li ZG; Lee MR
Rapid Commun Mass Spectrom; 2011 Jan; 25(1):25-32. PubMed ID: 21154651
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of higenamine metabolites in human urine by quadrupole-orbitrap LC-MS/MS for doping control.
Zhao X; Yuan Y; Wei H; Fei Q; Luan Z; Wang X; Xu Y; Lu J
J Pharm Biomed Anal; 2022 May; 214():114732. PubMed ID: 35325800
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
